Inhibrx Biosciences
Develops biologic drug candidates led by ozekibart and INBRX-106.
$123.41
After-hours close−0.23 (−0.19%)
At close$123.64(−0.23%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.45 | — | — |
| Aug 2026 | −$2.28 | −$2.34 | −2.6% |
| Aug 2026 | −$2.28 | −$2.34 | −2.6% |
| May 2026 | −$2.37 | −$2.15 | +9.3% |
| Mar 2026 | −$2.08 | −$2.11 | −1.4% |
The latest year is open to everyone — the 31 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jun 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$2.45 | — | — | $1.9M | — | — |
| Aug 13, 2026 | −$2.28 | −$2.34 | −2.6% | — | — | — |
| Aug 12, 2026 | −$2.28 | −$2.34 | −2.6% | — | $0 | — |
| May 14, 2026 | −$2.37 | −$2.15 | +9.3% | — | — | — |
| Mar 19, 2026 | −$2.08 | −$2.11 | −1.4% | $1.1M | — | — |
The latest year is open to everyone — the 31 quarters behind it read with an account. Sign in | ||||||
| Nov 14, 2025 | ||||||
| Aug 13, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 17, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 13, 2024 | ||||||
| Jun 3, 2024 | ||||||
| Feb 28, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 8, 2023 | ||||||
| Mar 6, 2023 | ||||||
| Nov 7, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 9, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 12, 2021 | ||||||
| Nov 13, 2020 | ||||||
| Aug 19, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||
| Dec 31, 2017 | ||||||